Keywords: Valeant Pharma, Medicis Pharma, M&A, Dermatology products

Valeant on the prowl again, with bid to buy Medicis for about $2.6 billion

Article | 04 September 2012

Print This

In a sixth acquisition so far this year, as well as several takeovers the previous year, Canada’s Valeant ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in